欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
CPI-360_1802175-06-9_产品详情
1802175-06-9
  • names:

    CPI-360

  • CAS号:

    1802175-06-9

    MDL Number:
  • MF(分子式): C25H31N3O4 MW(分子量): 437.53
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
CPI-360
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM001320-5mg 5mg 99.14% ¥ 2160.00 ¥ 2160.00 2-3天
- +
¥ 0.00
YZM001320-2mg 2mg 99.14% ¥ 1378.00 ¥ 1378.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名 CPI-360
CAS号 1802175-06-9
Inchi
InchiKey
分子式 Formula C25H31N3O4
分子量 Molecular Weight 437.53
溶解度Solubility 生物体外In Vitro:DMSO溶解度≥ 48.9 mg/mL(111.76 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知.
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
产品说明
IntroductionCPI60 is a potent, selective EZH2inhibitor with IC50 of 0.5 nM and 2.5 nM nM for wt EZH2 and Y641N EZH2, respectively. IC50 value: 0.5 nM, 2.5 nM
Application1
Application2
Application3
CPI-360 is a potent, selective EZH2inhibitor with IC50 of 0.5 nM and 2.5 nM nM for wt EZH2 and Y641N EZH2, respectively. IC50 value: 0.5 nM, 2.5 nM Target: EZH2 in vitro: CPI-360 functions on the basis of S-adenosyl-Lmethionine (SAM)-competition, inhibits EZH1 about 100-fold less and shows exquisite selectivity across a large panel of histone lysine and arginine, and DNA methyltransferases. CPI-360 potently reduced global H3K27me3 and H3K27me2 levels in a dosedependent manner. CPI-360 effectively suppressed heavy H3K27me3 incorporation in KARPAS-422 cells without affecting total histone turnover. CPI-360 treatment causes time-dependent transcriptional changes in germinal center B cell-like diffuse large B cell lymphoma. in vivo: Twice daily, subcutaneous administration of 200 mg/kg of CPI-360 reduced tumor growth (TGI 44%) of KARPAS-422 xenografts in mice without affecting body weight or causing any overt adverse effects. CPI-360 completely inhibits EZH2 catalytic activity, since we entirely suppress H3K27me3 turnover over time.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Bradley WD, et al. EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation. Chem Biol. 2014 Nov 20;21(11):1463-1475.
【2】.Bruno NC, et al. Design and Preparation of New Palladium Precatalysts for C-C and C-N Cross-Coupling Reactions. Chem Sci. 2013;4:916-920.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents